Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 4/20 | 0.62 |
| ▸ | HPGD | P15428 | 4/20 | 0.62 |
| ▸ | POLB | P06746 | 2/20 | 0.62 |
| ▸ | MAPT | P10636 | 1/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.53 |
| ▸ | NPC1 | O15118 | 2/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pifoxime SCHEMBL29849546 | 1.00 | RAB9A (0.62) | RAB9AHPGDPOLBMAPTALDH1A1 | |
| Mofoxime SCHEMBL2734610 | 0.87 | FKBP1A (0.67) | RAB9AHPGDPOLBMAPTALDH1A1 | |
| SCHEMBL335348 | 0.84 | RAB9A (0.66) | RAB9AHPGDPOLBMAPTALDH1A1 | |
| SCHEMBL8284320 | 0.80 | RAB9A (0.72) | RAB9AHPGDPOLBMAPTALDH1A1 | |
| SCHEMBL15543792 | 0.78 | HPGD (0.48) | RAB9AHPGDPOLBMAPTALDH1A1 | |
| SCHEMBL15543793 | 0.78 | HPGD (0.48) | RAB9AHPGDPOLBMAPTALDH1A1 | |
| SCHEMBL14437957 | 0.77 | FKBP1A (0.74) | RAB9AHPGDPOLBMAPTALDH1A1 | |
| SCHEMBL19705176 | 0.77 | HPGD (1.00) | RAB9AHPGDPOLBMAPTALDH1A1 | |
| SCHEMBL10064244 | 0.76 | MEN1 (0.83) | RAB9AHPGDPOLBMAPTALDH1A1 | |
| SCHEMBL14725172 | 0.76 | FKBP1A (0.75) | RAB9AHPGDPOLBMAPTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2944 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200323883-A1 | METHODS FOR TREATING AND PREVENTING VIRAL INFECTIONS | ENTERIN, INC. (US) | 2020-10-15 | — | — | US | claimed |
| US-10478444-B2 | Methods and compositions for treating and preventing viral infections | ENTERIN, INC. (US) | 2019-11-19 | — | — | US | claimed |
| US-20180133230-A1 | METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING VIRAL INFECTIONS | ENTERIN LABORATORIES, INC. (US) | 2018-05-17 | — | — | US | claimed |
| US-20140328792-A1 | METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING VIRAL INFECTIONS | ENTERIN, INC. | 2014-11-06 | — | — | US | claimed |
| US-20120183600-A1 | NOVEL COMPOSITION FOR TREATING METABOLIC SYNDROME AND OTHER CONDITIONS | CHEN CHIEN-HUNG (US) | 2012-07-19 | — | — | US | claimed |
| WO-2011066260-A2 | FORMULATIONS COMPRISING AMINOSTEROLS | ZASLOFF MICHAEL (US) | 2011-06-03 | — | — | WO | claimed |
| US-20110123624-A1 | FORMULATIONS COMPRISING AMINOSTEROLS | ENTERIN, INC. | 2011-05-26 | — | — | US | claimed |
| WO-2011056650-A2 | METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING VIRAL INFECTIONS | ZASLOFF MICHAEL (US) | 2011-05-12 | — | — | WO | claimed |
| US-20110097303-A1 | METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING VIRAL INFECTIONS | ENTERIN, INC. | 2011-04-28 | — | — | US | claimed |
| EP-2079756-A2 | SYNTHETIC PEPTIDE AMIDES AND DIMERS THEREOF | Cara Therapeutics, Inc. (US) | 2009-07-22 | — | — | EP | claimed |
| EP-0786999-A4 | COMBINATION METHOD FOR ACNE TREATMENT | MERCK & CO INC (US) | 1999-01-20 | — | — | EP | claimed |
| EP-0792371-A4 | COMBINATION METHOD FOR ACNE TREATMENT | MERCK & CO INC (US) | 1998-12-30 | — | — | EP | claimed |
| US-5811078-A | IN A SOLVENT MIXTURE WITH ETHYL OR ISOPROPYL ALCOHOL AND WATER | ADOLOR CORPORATION (US) | 1998-09-22 | — | — | US | claimed |
| EP-0852494-A2 | PERIPHERALLY ACTIVE ANTI-HYPERALGESIC OPIATES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1998-07-15 | — | — | EP | claimed |
| EP-0792371-A1 | COMBINATION METHOD FOR ACNE TREATMENT | Merck & Co., Inc. (US) | 1997-09-03 | — | — | EP | claimed |
| EP-0786999-A1 | COMBINATION METHOD FOR ACNE TREATMENT | Merck & Co., Inc. (US) | 1997-08-06 | — | — | EP | claimed |
| WO-1997009973-A2 | PERIPHERALLY ACTIVE ANTI-HYPERALGESIC OPIATES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1997-03-20 | — | — | WO | claimed |
| US-5543417-A | 5 Alpha-reductase inhibitor and at least one of an antibacterial agent, a keratolytic agent or an anti-inflammatory agent | MERCK & CO., INC. (US) | 1996-08-06 | — | — | US | claimed |
| WO-1996012487-A1 | COMBINATION METHOD FOR ACNE TREATMENT | MERCK & CO., INC. (US) | 1996-05-02 | — | — | WO | claimed |
| WO-1996012817-A1 | COMBINATION METHOD FOR ACNE TREATMENT | MERCK & CO., INC. (US) | 1996-05-02 | — | — | WO | claimed |